These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2568469)

  • 1. Analgesic effects of 3-methoxybenzamide in rats.
    Sanders R; Dill RE; Dorris RL; Miller EG
    J Pharm Pharmacol; 1989 Apr; 41(4):268-9. PubMed ID: 2568469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical analgesia produced by low doses of the opiate-antagonist naloxone is mediated by interaction at a site with characteristics of the delta opioid receptor.
    Taiwo YO; Basbaum AI; Perry F; Levine JD
    J Pharmacol Exp Ther; 1989 Apr; 249(1):97-100. PubMed ID: 2540325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats.
    Fang F; Guo TZ; Davies MF; Maze M
    Eur J Pharmacol; 1997 Oct; 336(2-3):137-41. PubMed ID: 9384225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF; Cook L
    J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of mu antagonists after naloxone non-reversible stress-induced analgesia.
    Sacerdote P; Mantegazza P; Panerai AE
    Brain Res; 1985 Dec; 359(1-2):34-8. PubMed ID: 3000523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat.
    Guo TZ; Poree L; Golden W; Stein J; Fujinaga M; Maze M
    Anesthesiology; 1996 Oct; 85(4):846-52. PubMed ID: 8873555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible DA agonist properties of naloxone.
    Feigenbaum J; Yanai J; Blass R
    Int J Neurosci; 1982 Nov; 17(3):139-44. PubMed ID: 6302020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A; Ceresoli G; Mandelli V; Parenti M
    J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of some benzamide derivatives on stress-induced behavior and striatum dopamine receptors.
    Bondarenko NA; Gorantcheva J; Tyutyulkova N; Nikolova M; Valdman AV
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):629-33. PubMed ID: 3236937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-tolerance between analgesic low doses of morphine and naloxone in arthritic rats.
    Kayser V; Guilbaud G
    Brain Res; 1987 Mar; 405(1):123-9. PubMed ID: 3032345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempted reversal of cocaine-induced antinociceptive effects with naloxone, an opioid antagonist.
    Pertovaara A; Mecke E; Carlson S
    Eur J Pharmacol; 1991 Jan; 192(3):349-53. PubMed ID: 1647316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of eptazocine, a novel analgesic, with opioid receptors.
    Nabeshima T; Matsuno K; Kamei H; Kameyama T
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):173-81. PubMed ID: 2992058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats.
    Eschalier A; Montastruc JL; Devoize JL; Rigal F; Gaillard-Plaza G; Pechadre JC
    Eur J Pharmacol; 1981 Aug; 74(1):1-7. PubMed ID: 6274647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antinociceptive activity of meptazinol depends on both opiate and cholinergic mechanisms.
    Bill DJ; Hartley JE; Stephens RJ; Thompson AM
    Br J Pharmacol; 1983 May; 79(1):191-9. PubMed ID: 6307452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dopaminergic receptor stimulation and opioid receptor blockade on GH incretion: preliminary findings.
    Ghisoli E; Benfenati F; Pancaldi L; Meringolo D; Catenacci M
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1222-5. PubMed ID: 6257257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.
    Walker MJ; Lê AD; Poulos CX; Cappell H
    Brain Res; 1991 Jan; 538(2):181-6. PubMed ID: 1849435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the effects of the acute and chronic administration of phencyclidine on body temperature in the rat: lack of evidence for the involvement of opiate receptors.
    Pechnick RN; George R
    J Pharmacol Exp Ther; 1989 Mar; 248(3):900-6. PubMed ID: 2539463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
    Chen SR; Pan HL
    Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal haloperidol alters striatal dopamine and opiate receptors.
    Moon SL
    Brain Res; 1984 Dec; 323(1):109-13. PubMed ID: 6098328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.